Participants 336 424 6
G-CSF group which received chemotherapy with G-CSF and historical controls without G-CSF
Participants 429 597 9
evaluated 132 patients with hematological malignancy in complete remission without any main organ dysfunction who had been treated between April 1983 and December 1997.
Participants 614 714 4
incidence of ARDS due to pulmonary infection between those who received G-CSF and those who did not.
